Last reviewed · How we verify

Oxygen + Midazolam — Competitive Intelligence Brief

Oxygen + Midazolam (Oxygen + Midazolam) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Supportive care combination (oxygen + benzodiazepine). Area: Anesthesia/Procedural Sedation.

marketed Supportive care combination (oxygen + benzodiazepine) GABA-A receptor (midazolam component) Anesthesia/Procedural Sedation Small molecule Live · refreshed every 30 min

Target snapshot

Oxygen + Midazolam (Oxygen + Midazolam) — Unity Health Toronto. Oxygen increases blood oxygen saturation while midazolam provides sedation and anxiolysis via GABA-A receptor modulation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Oxygen + Midazolam TARGET Oxygen + Midazolam Unity Health Toronto marketed Supportive care combination (oxygen + benzodiazepine) GABA-A receptor (midazolam component)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Supportive care combination (oxygen + benzodiazepine) class)

  1. Unity Health Toronto · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oxygen + Midazolam — Competitive Intelligence Brief. https://druglandscape.com/ci/oxygen-midazolam. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: